Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: J Vasc Surg. 2023 Oct 14;79(2):397–404. doi: 10.1016/j.jvs.2023.10.005

Table II.

Risk Factors, Comorbidities and Mediations of PAD patients and Normal Controls

Normal Controls (n=13) PAD Patients (n=15)
Risk Factors & Comorbidities, n (%)
Current Smoker 1 (8) 5 (33)
Past Smoker 5 (38) 8 (53)
Coronary Artery Disease 0 (0) 6 (40)
Hypertension 8 (62) 9 (60)
Dyslipidemia 5 (38) 13 (87)
Diabetes 3 (23) 9 (60)
Lung Disease (COPD) 2 (15) 1 (7)
Renal Insufficiency 0 (0) 0 (0)
Prior Revascularization 0 (0) 5 (33)
Medications, n (%)
Statin 4 (31) 9 (60)
β-blocker 0 (0) 4 (27)
ACE Inhibitor 1 (8) 2 (13)
Calcium channel blocker 2 (15) 2 (13)
Angiotensin II Receptor Agonist 3 (23) 1 (7)
Diuretic 4 (31) 1 (7)
Aspirin 5 (38) 9 (60)
Anticoagulants 0 (0) 1 (7)
Oral Diabetes 0 (0) 5 (33)
Insulin 2 (15) 1 (7)

COPD: Chronic obstructive pulmonary disease